Özalkak, Ş. Et Al. 2023. Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year. Journal of clinical research in pediatric endocrinology , vol.15, no.3 , 329-333.

Özalkak, Ş., Demiral, M., Ünal, E., Taş, F. F., Onay, H., DEMİRBİLEK, H., ... Özbek, M. N.(2023). Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year. Journal of clinical research in pediatric endocrinology , vol.15, no.3, 329-333.

Özalkak, Şervan Et Al. "Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year," Journal of clinical research in pediatric endocrinology , vol.15, no.3, 329-333, 2023

Özalkak, Şervan Et Al. "Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year." Journal of clinical research in pediatric endocrinology , vol.15, no.3, pp.329-333, 2023

Özalkak, Ş. Et Al. (2023) . "Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year." Journal of clinical research in pediatric endocrinology , vol.15, no.3, pp.329-333.

@article{article, author={Şervan Özalkak Et Al. }, title={Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year}, journal={Journal of clinical research in pediatric endocrinology}, year=2023, pages={329-333} }